Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinoma
Masashi Fujita, Atsushi Takahashi, Manabu Hayashi, et al.
Hepatology Research (2019) Vol. 49, Iss. 7, pp. 778-786
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments
Giovanni Marasco, Matteo Serenari, Matteo Renzulli, et al.
Journal of Gastroenterology (2020) Vol. 55, Iss. 10, pp. 927-943
Open Access | Times Cited: 87
Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib
Haruki Uojima, Makoto Chuma, Yoshiaki Tanaka, et al.
Liver Cancer (2019) Vol. 9, Iss. 2, pp. 193-206
Open Access | Times Cited: 77
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 4, pp. 432-448
Open Access | Times Cited: 54
Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis
Yusheng Guo, Yanqiao Ren, Licheng Zhu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis
Chuan Jiang, Yanyan Wang, Wei Fu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 23
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib
Dong Dong, Jinyu Shi, Xiao Shang, et al.
Medicine (2022) Vol. 101, Iss. 5, pp. e28680-e28680
Open Access | Times Cited: 19
The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients
Jing Long, Xin Zhang, Wei Mi, et al.
Aging (2024)
Open Access | Times Cited: 4
The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors
Wei Sun, Xue Yin, Xiaomin Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Nutritional therapy for hepatocellular carcinoma
Astrid Ruiz‐Margáin, Berenice M Román-Calleja, Paulina Moreno-Guillén, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 10, pp. 1440-1452
Open Access | Times Cited: 27
Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma
Keisuke Hirota, Takumi Kawaguchi, Shunji Koya, et al.
Hepatology Research (2019) Vol. 50, Iss. 3, pp. 330-341
Closed Access | Times Cited: 28
Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients
Hanaa Badran, Maha Elsabaawy, Amr Ragab, et al.
Asian Pacific Journal of Cancer Prevention (2020) Vol. 21, Iss. 11, pp. 3285-3290
Open Access | Times Cited: 26
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management
Paolo Gallo, Marianna Silletta, Antonio De Vincentis, et al.
Chemotherapy (2021) Vol. 67, Iss. 3, pp. 152-163
Open Access | Times Cited: 21
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan
Masashi Fujita, Kazumichi Abe, Hidekatsu Kuroda, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization
Tzu-Ping Chien, Song-Fong Huang, Wen‐Hui Chan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis
Xuanmei Li, Xue Huang, Lifu Lei, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 7
The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE
Ji Hyae Lim, Kyung Won Kim, Yousun Ko, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
Maurizio Biselli, Nicola Reggidori, Massimo Iavarone, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1080-1080
Open Access | Times Cited: 2
Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
Andrew S. deLemos, Jing Zhao, Milin Patel, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 3, pp. 393-404
Open Access | Times Cited: 2
Skeletal-muscle index predicts survival after percutaneous transhepatic biliary drainage for obstructive jaundice due to perihilar cholangiocarcinoma
Jin-Xing Zhang, Ding Ye, Hai‐Tao Yan, et al.
Surgical Endoscopy (2020) Vol. 35, Iss. 11, pp. 6073-6080
Closed Access | Times Cited: 17
Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma
Takumi Kawaguchi, Sachiyo Yoshio, Yuzuru Sakamoto, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 936-936
Open Access | Times Cited: 16
Quantitative assessment of volumetric muscle loss: Dual-energy X-ray absorptiometry and ultrasonography
Marco Alessandro Minetto, Chiara Busso, Giulia Gamerro, et al.
Current Opinion in Pharmacology (2021) Vol. 57, pp. 148-156
Open Access | Times Cited: 15
Prognostic impact of sarcopenia in patients with hepatocellular carcinoma treated with PD-1 inhibitor
Yusheng Guo, Yanqiao Ren, Feihong Wu, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 10
High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Qiang Li, Lei Zhang, Zhong-Heng Hou, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature
Maria Guarino, Valentina Cossiga, Chiara Becchetti, et al.
Digestive and Liver Disease (2021) Vol. 54, Iss. 8, pp. 997-1006
Open Access | Times Cited: 14
Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy
Yusuke Sugama, Koji Miyanishi, Takahiro Osuga, et al.
JGH Open (2021) Vol. 5, Iss. 12, pp. 1335-1343
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top